TL;DR
Researchers have developed a novel, rapid, and highly sensitive biosensor platform for detecting SARS-CoV-2 antibodies in multiple animal species. This meta-surface plasmon resonance (MetaSPR) biosensor, enhanced with gold nanoparticles and polyethyleneimine, can screen animal serum for antibodies in just 30 minutes, offering a significant improvement over existing methods for animal epidemiological surveillance.
What Problem Does This Paper Address?
The COVID-19 pandemic highlighted the potential for zoonotic transmission of SARS-CoV-2, with numerous reports of infections in various animal species, including companion animals like cats and dogs, as well as wildlife like minks. This raises concerns about animal reservoirs facilitating viral evolution and potential re-emergence in humans. Current methods for detecting SARS-CoV-2 antibodies in animals face several challenges:
- Limited detection windows: Nucleic acid tests are only effective for a short period during active infection.
- Biosafety requirements: Virus or pseudovirus neutralization assays require high-level biosafety facilities (BSL-2 or BSL-3), limiting their widespread use.
- Species-specificity and labor intensity: Traditional methods like ELISA are often not designed for multispecies detection and are time-consuming and labor-intensive.
- Lack of rapid, high-throughput methods: Existing point-of-care methods are primarily developed for human use and may not be suitable or optimized for animal sera.
These limitations hinder effective epidemiological monitoring of SARS-CoV-2 in animal populations, making it difficult to track viral spread, identify at-risk animals, and assess the impact of vaccination or natural infection.
Methods
The core of this work is the development of a Polyethyleneimine-Gold Nanoparticle Meta-Surface Plasmon Resonance (PEI-GNPs MetaSPR) biosensor. Here's a breakdown of the key techniques:
- MetaSPR Biosensor Platform: This is the foundation, utilizing the principles of surface plasmon resonance (SPR) enhanced by nanostructured surfaces (meta-surface) to detect binding events. The system is integrated into a standard 96-well plate format, allowing for high-throughput analysis using common microplate readers.
- PEI Functionalization: Polyethyleneimine (PEI), a cationic polymer, is used to functionalize the chip surface. PEI's ability to adsorb anions quickly and efficiently enhances the binding of gold nanoparticles (GNPs) and improves the overall sensitivity of the biosensor.
- Gold Nanoparticle (GNP) Enhancement: GNPs with specific plasmonic properties are synthesized and used to label the SARS-CoV-2 spike (S)-trimer protein. These GNPs significantly amplify the SPR signal due to their potent surface plasmon absorption and light-scattering qualities, leading to increased sensitivity.
- SARS-CoV-2 S-Trimer Protein: A highly active, stabilized prefusion S-trimer protein was engineered and expressed. This protein serves as the antigen for antibody detection. Mutations were introduced to stabilize the protein in its prefusion form, which is crucial for capturing antibodies that target the virus's entry mechanism.
- Protein A Immobilization: Protein A, which binds to the Fc portion of IgG antibodies across various species, is immobilized on the biosensor chip. This allows for the capture of total IgG from different animal sera, enabling multispecies detection without the need for species-specific anti-IgG conjugates.
- Sandwich Assay Principle: The detection mechanism involves a sandwich assay. First, total IgG from the serum sample is captured by Protein A. Then, the GNP-labeled S-trimer protein is added, binding to the captured IgG. The resulting complex on the sensor surface generates a detectable SPR signal.
- Assay Optimization: Extensive optimization was performed for serum diluent, Protein A coating concentration, IgG capture time, and reaction time to achieve maximum signal-to-noise ratio and reproducibility.
Datasets
The study utilized several types of serum samples for evaluation:
- Negative Sera: Collected from dogs (n=51), cats (n=53), rabbits (n=6), and minks (n=52) before the SARS-CoV-2 epidemic outbreak.
- Positive Sera:
- Confirmed cat (n=52) and dog (n=10) positive samples identified via pseudovirus neutralization tests (pVNT).
- Immune sera from animals (dogs, cats, rabbits, minks) that were vaccinated with a recombinant spike trimer and inactivated vaccine.
- Control Sera:
- Three sera positive for feline infectious peritonitis virus.
- Three sera positive for canine coronavirus.
- Control groups injected with aluminum hydroxide and PBS (for vaccine studies).
The study also compared its performance against traditional methods using these sera. No new benchmark datasets were introduced; rather, existing serum samples were used to validate the new platform against established assays.
Key Insights and Ideas
- Multispecies Detection Simplified: The use of Protein A for universal IgG capture is a key innovation, eliminating the need for species-specific antibodies and greatly simplifying the assay for diverse animal populations.
- GNP Enhancement for Sensitivity: The strategic incorporation of gold nanoparticles dramatically boosts the sensitivity of the MetaSPR platform, allowing for the detection of low-concentration antibodies.
- Stabilized Prefusion S-Trimer: Utilizing a stabilized prefusion S-trimer protein is crucial for capturing antibodies that are most relevant to viral neutralization, as this conformation exposes key epitopes.
- Rapid, Automated Workflow: The entire detection process, from sample loading to result, is streamlined to just 30 minutes, making it highly suitable for rapid screening and high-throughput applications.
- High Specificity: The biosensor demonstrated 100% specificity in detecting antibodies in cats, dogs, and minks, with no cross-reactivity observed with sera from animals infected with other viruses like feline infectious peritonitis virus or canine coronavirus.
Key Results
- Speed: The assay can be completed in 30 minutes, a significant reduction compared to traditional methods.
- Specificity: Achieved 100% specificity for detection in cats, dogs, and minks.
- Coincidence Rate: Demonstrated a high coincidence rate of 99.36% (313/315) when compared to pseudovirus neutralization tests (pVNT) for clinical and immune sera.
- Sensitivity: The detection sensitivity for cat, dog, and mink serum was 2,048, 1,024, and 4,096 times better, respectively, than indirect ELISA. It was also comparable to indirect immunofluorescence assays.
- Reproducibility: Both intra- and interplate repeatability were good, with coefficients of variation (CV) generally below 10%, indicating the system's reliability.
- Detection Limits: The biosensor could detect positive results in cat, dog, and mink sera diluted up to 3,000, 1,600, and 6,400 times, respectively, outperforming S-trimer-ELISA in sensitivity.
Limitations and Future Work
- Limited Species Tested: While designed for multispecies detection, the study primarily validated the platform in cats, dogs, and minks. The authors acknowledge that applicability to other vulnerable or uncommon wild species may be affected by the binding strength of their IgG Fc segments to Protein A.
- Early Infection Detection: The biosensor is designed for antibody detection, which indicates past exposure or vaccination, not for diagnosing early-stage active infections.
- Omicron Variant: While the study suggests that sera immunized against mutant strains can be identified using wild-type S protein, the authors note that the Omicron strain has significantly changed, and further assessment with insufficient clinical serum samples was not performed.
Future Work:
- Investigate the applicability of this approach in a wider range of animal species.
- Further research is needed to determine its utility for certain vulnerable or uncommon wild species.
- The authors aim to make this an efficient method for COVID-19 epidemiology screening in animal serum.
Summary updated